Table 10.
Patient Number | Type of Lipodystrophy | Sex | Country | Age at Death, y | Cause(s) of Deatha |
---|---|---|---|---|---|
1 | CGL | Male | United States | 31 | Probable end-stage liver disease |
2 | CGL | Male | United States | 32 | Atypical interstitial pneumonitis; respiratory failure |
3 | CGL | Male | Turkey | 44 | Died after coronary artery bypass grafting operation |
4 | CGL | Female | Turkey | 62 | Myocardial infarction |
5 | CGL | Female | Turkey | 26 | Diabetic foot infection |
6 | CGL | Female | United States | 30 | Cardiac arrest due to underlying nonischemic cardiomyopathy |
7 | CGL | Female | Brazil | 16 | Sepsis |
8 | CGL | Female | United States | 18 | Heart failure related to valvular stenosis |
9 | CGL | Female | Brazil | 15 | Septic shock |
10 | CGL | Female | Turkey | 60 | Stroke |
11 | FPLD | Male | Turkey | 35 | Not documented |
12 | FPLD | Male | United States | 69 | Not documented |
13 | FPLD | Male | United States | 63 | Not documented |
14 | FPLD | Female | United States | 39 | Not documented |
15 | FPLD | Female | United States | 69 | Probable kidney failure |
16 | FPLD | Female | Brazil | 60 | Hepatic cirrhosis |
17 | FPLD | Female | Brazil | 34 | Hypovolemic shock |
18 | FPLD | Female | United States | 52 | Possible cardiac episode |
As reported in patient medical records and by study investigators.